The Link between Oral and Gut Microbiota in Inflammatory Bowel Disease and a Synopsis of Potential S

Abstract

The objective of this review is to provide recent evidence for the oral&ndashgut axis connection and to discuss gastrointestinal (GI) immune response, inflammatory bowel disease (IBD) pathogenesis, and potential salivary biomarkers for determining GI health. IBD affects an estimated 1.3% of the US adult population. While genetic predisposition and environment play a role, abnormal immune activity and microbiota dysbiosis within the gastrointestinal tract are also linked in IBD pathogenesis. It has been inferred that a reduced overall richness of bacterial species as well as colonization of opportunistic bacteria induce systemic inflammation in the GI tract. Currently, there is supporting evidence that both oral and gut microbiota may be related to the development of IBD. Despite this, there are currently no curative therapies for IBD, and diagnosis requires samples of blood, stool, and invasive diagnostic imaging techniques. Considering the relative ease of collection, emerging evidence of association with non-oral diseases may imply that saliva microbiome research may have the potential for gut diagnostic or prognostic value. This review demonstrates a link between saliva and intestinal profiles in IBD patients, suggesting that saliva sampling has the potential to serve as a non-invasive biomarker for gut diseases such as IBD in the oral&ndashgut axis.

Cite this article

Bartlett A, Gullickson RG, Singh R, Ro S, Omaye ST. The Link between Oral and Gut Microbiota in Inflammatory Bowel Disease and a Synopsis of Potential Salivary Biomarkers. Applied Sciences. 2020; 10(18):6421.https://doi.org/10.3390/app10186421

View full text

>> Full Text:   The Link between Oral and Gut Microbiota in Inflammatory Bowel Disease and a Synopsis of Potential S